CBD Company Fundraising for UK Child’s Cannabis Medicine as NHS Denials Continue

United Kingdom-based CBD company Green Active is donating some profits to a Scottish boy suffering from Doose Syndrome, a severe form of epilepsy, as the National Health Service continues denying to cover the costs of cannabis-based medications, the Daily Record reports.

Eight-year-old Murray Gray was diagnosed with the disease in 2017 and had up to 12 seizures a day, eventually ending up in a vegetative state in the hospital. His mother, Karen, said he has been seizure-free for 15 months after he started taking Bedrolite and Bedica – which are approved for use in the UK – but the regimen runs £1,400 per month and the NHS refuses to write a prescription which would provide it to the family for free.

Jo Devall, co-owner of Green Active with his partner Melissa Lopes Correa, said he learned about the boy via Twitter and his story “resonated” with him. All sales using the code FORMURRAY will be donated to Gray’s family and customers who use that code will also get 10 percent off.

“…I just wished I could do something to help. Then it occurred to me that I could provide something to this family. It fits with who we are as people and the way we live our lives.” – Devall to the Record

He explained that funding the boy’s medicine wouldn’t bankrupt the company because they will still take their operating costs “but all the profit after that will go to Murray.”

Karen called the plan “absolutely brilliant” even though neither she nor GreenActive knew exactly how much the campaign might raise. She criticized the NHS inaction since Bedrolite and Bedica were added to the service two years ago.

“We should have a prescription for this rather than having to rely on our friends, family and the kindness of companies to pay for it,” she said.

According to pro-medical cannabis group End Our Pain, the NHS has issued just three prescriptions for medical cannabis oil since it was legalized for use on the national health care plan two years ago.